Live from the NIH registry
Studies recruiting near Fontana right now
Top 25 of 965 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Loma Linda University Medical Center — Loma Linda, California (11.9 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
City of Hope National Medical Center — Duarte, California (29.7 mi)
· Sponsor: Relay Therapeutics, Inc.
Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Primary Membranous Nephropathy
Phase 2
Interventional 30 participants sought
Research Site — Loma Linda, California (11.9 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Loma Linda University Medical Center — Loma Linda, California (11.9 mi)
· Sponsor: Medtronic MiniMed, Inc.
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
Phase 1, Phase 2
Interventional 450 participants sought
City of Hope ( Site 0014) — Duarte, California (29.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Duarte, California (29.7 mi)
· Sponsor: AstraZeneca
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-Fontana — Fontana, California (1.5 mi)
· Sponsor: SWOG Cancer Research Network
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
City of Hope — Duarte, California (29.7 mi)
· Sponsor: Nurix Therapeutics, Inc.
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
North America Research Institute — San Dimas, California (19.9 mi)
· Sponsor: R1 Therapeutics
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
MTAP-deleted Solid Tumors
Phase 1, Phase 2
Interventional 450 participants sought
City of Hope - Duarte Cancer Center — Duarte, California (29.7 mi)
· Sponsor: Bayer
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Phase 1
Interventional 36 participants sought
City of Hope Medical Center — Duarte, California (29.7 mi)
· Sponsor: PeproMene Bio, Inc.
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Kaiser Permanente-Fontana — Fontana, California (1.5 mi)
· Sponsor: NRG Oncology
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Riverside Community Hospital — Riverside, California (10.6 mi)
· Sponsor: Duke University
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
Kaiser Permanente Fontana Medical Center — Fontana, California (1.5 mi)
· Sponsor: Joseph Broderick, MD
A Registry for People With T-cell Lymphoma
Multiple conditions
N/A
Observational 1,000 participants sought
City of Hope Cancer Center (Data collection only) — Duarte, California (29.7 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy
Cancer, Neoplasms
N/A
Interventional 35 participants sought
UCI Health - Yorba Linda — Yorba Linda, California (24.8 mi)
· Sponsor: University of California, Irvine
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Velocity Clinical Research - San Bernardino — San Bernardino, California (9.8 mi)
· Sponsor: Crystalys Therapeutics
Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma
Recurrent Plasmablastic Lymphoma, Refractory Plasmablastic Lymphoma
Phase 1
Interventional 30 participants sought
City of Hope Comprehensive Cancer Center LAO — Duarte, California (29.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Loma Linda University Medical Center — Loma Linda, California (11.9 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluating the Impact of Training for IHSS Workers
Home Care for Elderly or Disabled Individuals
N/A
Interventional 2,500 participants sought
San Bernardino County — San Bernardino, California (9.8 mi)
· Sponsor: Abdul Latif Jameel Poverty Action Lab
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
IgA Nephropathy
Phase 4
Interventional 60 participants sought
Loma Linda University — San Bernardino, California (9.8 mi)
· Sponsor: Calliditas Therapeutics AB
CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia
Phase 1
Interventional 27 participants sought
City of Hope Medical Center — Duarte, California (29.7 mi)
· Sponsor: City of Hope Medical Center
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
Phase 3
Interventional 440 participants sought
Research Site — Riverside, California (10.6 mi)
· Sponsor: AstraZeneca
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site - 7074 — Corona, California (16.5 mi)
· Sponsor: Galderma R&D
Visuomotor Prosthetic for Paralysis
Quadriplegia
N/A
Interventional 2 participants sought
Casa Colina Centers for Rehabilitation — Pomona, California (17.0 mi)
· Sponsor: Richard A. Andersen, PhD